1. Home
  2. ACH vs ELOX Comparison

ACH vs ELOX Comparison

Compare ACH & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Accendra Health Inc.

ACH

Accendra Health Inc.

N/A

Current Price

$0.43

Market Cap

68.4M

Sector

N/A

ML Signal

N/A

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$14.95

Market Cap

60.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ACH
ELOX
Founded
1882
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
68.4M
60.3M
IPO Year
2001
2013

Fundamental Metrics

Financial Performance
Metric
ACH
ELOX
Price
$0.43
$14.95
Analyst Decision
Hold
Strong Buy
Analyst Count
5
4
Target Price
$1.51
★ $38.25
AVG Volume (30 Days)
★ 1.3M
18.6K
Earning Date
10-29-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 41.67
EPS
★ N/A
N/A
Revenue
★ $2,762,032,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.97
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.44
$10.00
52 Week High
$4.69
$23.40

Technical Indicators

Market Signals
Indicator
ACH
ELOX
Relative Strength Index (RSI) 16.16 43.09
Support Level N/A $13.98
Resistance Level $1.26 $19.43
Average True Range (ATR) 0.06 1.26
MACD 0.01 -0.11
Stochastic Oscillator 0.02 20.31

Price Performance

Historical Comparison
ACH
ELOX

About ACH Accendra Health Inc.

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: